1
|
Nguyen KA, Matte A, Foresti R, Federti E, Kiger L, Lefebvre C, Hocini H, Pelinski Y, Kitagishi H, Bencheikh L, Pirenne F, De Franceschi L, Motterlini R, Bartolucci P. An Oral Carbon Monoxide-Releasing Molecule Protects against Acute Hyper-hemolysis in Sickle Cell Disease. Blood 2024:blood.2023023165. [PMID: 38518106 DOI: 10.1182/blood.2023023165] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/08/2023] [Revised: 03/06/2024] [Accepted: 03/17/2024] [Indexed: 03/24/2024] Open
Abstract
Acute hyper-hemolysis is a severe life-threatening complication in patients with sickle cell disease (SCD) that may occur during delayed hemolytic transfusion reaction (DHTR), or vaso-occlusive crises associated with multi-organ failure. Here, we developed in vitro and in vivo animal models to mimic endothelial damage during the early phase of hyper-hemolysis in SCD. We then used the carbon monoxide (CO)-releasing molecule CORM-401 and examined its effects against endothelial activation, damage, and inflammation inflicted by hemolysates containing red blood cell membrane-derived particles. The in vitro results revealed that CORM-401: 1) prevented the up-regulation of relevant pro-inflammatory, and pro-adhesion controlled by the nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB), and 2) abolished the expression of the nuclear factor erythroid-2-related factor 2 (Nrf2) that regulates the inducible antioxidant cell machinery. We also show in SCD mice that CORM-401 protects against hemolysate-induced acute damage of target organs such as the lung, liver, and kidney through modulation of NF-kB pro-inflammatory and Nrf2 antioxidant pathways. Our data demonstrate the efficacy of CORM-401 as a novel therapeutic agent to counteract hemolysate-induced organ damage during hyper-hemolysis in SCD. This approach might be considered as possible preventive treatment in high-risk situations such as SCD patients with history of DHTR.
Collapse
Affiliation(s)
- Kim Anh Nguyen
- Etablissement Français du Sang, Île-de-France Mondor; Laboraroire d'Excellence, INSERM U955, IMRB, Team Pirenne, Créteil, France
| | - Alessandro Matte
- Dept of Medicine, University of Verona and Azienda Ospedaliera Universitaria Integrata di Verona, Verona, Italy
| | - Roberta Foresti
- University Paris-Est Créteil, INSERM, IMRB, F-94010, Créteil, France
| | - Enrica Federti
- Dept of Engineering for innovative medicine -DIMI , University of Verona and Azienda Ospedaliera Universitaria Integrata di Verona, Verona, Italy
| | | | | | | | | | | | | | - France Pirenne
- University Paris Est Créteil, INSERM U955, Etablissement Francais du Sang, Creteil, France
| | | | | | | |
Collapse
|
2
|
Boukezoula TF, Bencheikh L, Belkhiat DEC. A heterogeneous mathematical model for a spherical fixed bed axial flow reactor applied to a naphtha reforming process: enhancing performance challenge using a non-uniform catalyst distribution in the pellet. Reac Kinet Mech Cat 2022. [DOI: 10.1007/s11144-022-02257-z] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
|
3
|
Kim-Anh NP, Kiger L, Decrouy X, Bencheikh L, Habibi A, Pirenne F, Roumenina L, Bartolucci P. S299: ROLE OF RED BLOOD CELL MEMBRANE-DERIVED PARTICLES ON ENDOTHELIAL DAMAGES DURING ONSET STAGE OF DELAYED HEMOLYTIC TRANSFUSION REACTION. Hemasphere 2022. [DOI: 10.1097/01.hs9.0000844088.18349.27] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022] Open
|
4
|
Bencheikh L, Nguyen KA, Chadebech P, Kiger L, Bodivit G, Jouard A, Pakdaman S, Adypagavane S, Audureau E, Tebbakha K, Bocquet T, Mignen B, Hebert N, Seguin M, Pirenne F, Sowemimo-Coker S, Dunham A, Bartolucci P. Preclinical evaluation of the preservation of red blood cell concentrates by hypoxic storage technology for transfusion in sickle cell disease. Haematologica 2022; 107:1944-1949. [PMID: 35354249 PMCID: PMC9335112 DOI: 10.3324/haematol.2021.279721] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/04/2021] [Indexed: 12/05/2022] Open
Affiliation(s)
- Laura Bencheikh
- Etablissement Français du Sang (EFS) Ile-de-France; Univ Paris Est Creteil, INSERM, IMRB, F-94010 Creteil
| | - Kim-Anh Nguyen
- Univ Paris Est Creteil, INSERM, IMRB, F-94010 Creteil, France; Institut Imagine, Paris
| | - Philippe Chadebech
- Etablissement Français du Sang (EFS) Ile-de-France; Univ Paris Est Creteil, INSERM, IMRB, F-94010 Creteil
| | - Laurent Kiger
- Univ Paris Est Creteil, INSERM, IMRB, F-94010 Creteil
| | - Gwellaouen Bodivit
- Etablissement Français du Sang (EFS) Ile-de-France; Univ Paris Est Creteil, INSERM, IMRB, F-94010 Creteil
| | - Alicia Jouard
- Etablissement Français du Sang (EFS) Ile-de-France; Univ Paris Est Creteil, INSERM, IMRB, F-94010 Creteil
| | | | - Sandia Adypagavane
- Etablissement Français du Sang (EFS) Ile-de-France; Univ Paris Est Creteil, INSERM, IMRB, F-94010 Creteil
| | - Etienne Audureau
- CHU Henri Mondor, Assistance publique-hôpitaux de Paris, Creteil
| | | | | | | | - Nicolas Hebert
- Etablissement Français du Sang (EFS) Ile-de-France; Univ Paris Est Creteil, INSERM, IMRB, F-94010 Creteil
| | - Marion Seguin
- Univ Paris Est Creteil, INSERM, IMRB, F-94010 Creteil
| | - France Pirenne
- Etablissement Français du Sang (EFS) Ile-de-France; Univ Paris Est Creteil, INSERM, IMRB, F-94010 Creteil
| | | | | | - Pablo Bartolucci
- Univ Paris Est Creteil, INSERM, IMRB, F-94010 Creteil, France; CHU Henri Mondor, Assistance publique-hôpitaux de Paris, Creteil.
| |
Collapse
|
5
|
Kiger L, Adypagavane S, Bencheikh L, Chadebech P, Pakdaman S, Hebert N, Moutereau S, Marden M, Galacteros F, Beuzard Y, Pirenne F, Bartolucci P. Dosage de l’hémolyse dans les anémies hémolytiques et le DHTR. Transfus Clin Biol 2021. [DOI: 10.1016/j.tracli.2021.08.307] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/19/2022]
|
6
|
Nguyen-Peyre KA, Kiger L, Decrouy X, Vingert B, Hocini H, Lefebvre C, Bencheikh L, Chadebech P, Baudin-Creuza V, Pakdaman S, Habibi A, Pirenne F, Bartolucci P. Nouveaux mécanismes de dysfonction endothéliale dans l’hémolyse intravasculaire. Transfus Clin Biol 2021. [DOI: 10.1016/j.tracli.2021.08.128] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022]
|
7
|
Hebert N, Rakotoson MG, Bodivit G, Audureau E, Bencheikh L, Kiger L, Oubaya N, Pakdaman S, Sakka M, Di Liberto G, Chadebech P, Vingert B, Pirenne F, Galactéros F, Cambot M, Bartolucci P. Quantification de l’hémoglobine fœtale dans des globules rouges individualisés. Transfus Clin Biol 2021. [DOI: 10.1016/j.tracli.2021.08.310] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/24/2022]
|
8
|
Hebert N, Rakotoson MG, Bodivit G, Audureau E, Bencheikh L, Kiger L, Oubaya N, Pakdaman S, Sakka M, Di Liberto G, Chadebech P, Vingert B, Pirenne F, Galactéros F, Cambot M, Bartolucci P. Individual red blood cell fetal hemoglobin quantification allows to determine protective thresholds in sickle cell disease. Am J Hematol 2020; 95:1235-1245. [PMID: 32681733 DOI: 10.1002/ajh.25937] [Citation(s) in RCA: 17] [Impact Index Per Article: 4.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/07/2020] [Revised: 07/06/2020] [Accepted: 07/10/2020] [Indexed: 02/04/2023]
Abstract
Polymerization of the sickle hemoglobin (HbS) is a key determinant of sickle cell disease (SCD), an inherited blood disorder. Fetal hemoglobin (HbF) is a major modulator of the disease severity by both decreasing HbS intracellular concentration and inhibiting its polymerization. However, heterocellular distribution of HbF is common in SCD. For HbS polymerization inhibition, the hypothesis of an "HbF per red blood cell (HbF/RBC) threshold" requires accurate measurement of HbF in individual RBC. To date, HbF detection methods are limited to a qualitative measurement of RBC populations containing HbF - the F cells, which are variable. We developed an accurate method for HbF quantification in individual RBC. A linear association between mean HbF content and mean RBC fluorescence by flow cytometry, using an anti-Human-HbF antibody, was obtained from non-SCD subjects presenting homogeneous HbF distribution. This correlation was then used to measure HbF/RBC. Hydroxyurea (HU) improves SCD clinical manifestations, mainly through its ability to induce HbF synthesis. The HbF distribution was analyzed in 14 SCD patients before and during HU treatment. A significant decrease in RBC population containing less than 2 pg of HbF/RBC was observed. Therefore, we tested associations for %RBC above different HbF/RBC thresholds and showed a decrease in the pathognomonic vaso-occlusive crisis incidence from the threshold of 4 pg. This quantity was also correlated with the level of sickle RBC after in vitro deoxygenation. This new method allows the comparison of HbF/RBC distributions and could be a useful tool to characterize baseline patients HbF distribution and therapeutic response to HbF inducers.
Collapse
Affiliation(s)
- Nicolas Hebert
- Institut Mondor de Recherche Biomédicale, Unité 955, team Pirenne, INSERM, EFS, UPEC, Laboratory of excellence LABEX GRex Créteil France
- Etablissement Français du Sang, Île‐de‐France, Hôpital Henri Mondor Créteil France
- Sickle cell referral center, UMGGR Plateforme d'expertise Maladies Rares Grand Paris Est, UPEC Hôpitaux Universitaires Henri Mondor, APHP Créteil France
| | - Marie Georgine Rakotoson
- Institut Mondor de Recherche Biomédicale, Unité 955, team Pirenne, INSERM, EFS, UPEC, Laboratory of excellence LABEX GRex Créteil France
| | - Gwellaouen Bodivit
- Institut Mondor de Recherche Biomédicale, Unité 955, team Pirenne, INSERM, EFS, UPEC, Laboratory of excellence LABEX GRex Créteil France
- Etablissement Français du Sang, Île‐de‐France, Hôpital Henri Mondor Créteil France
| | - Etienne Audureau
- Sickle cell referral center, UMGGR Plateforme d'expertise Maladies Rares Grand Paris Est, UPEC Hôpitaux Universitaires Henri Mondor, APHP Créteil France
| | - Laura Bencheikh
- Institut Mondor de Recherche Biomédicale, Unité 955, team Pirenne, INSERM, EFS, UPEC, Laboratory of excellence LABEX GRex Créteil France
- Sickle cell referral center, UMGGR Plateforme d'expertise Maladies Rares Grand Paris Est, UPEC Hôpitaux Universitaires Henri Mondor, APHP Créteil France
| | - Laurent Kiger
- Institut Mondor de Recherche Biomédicale, Unité 955, team Pirenne, INSERM, EFS, UPEC, Laboratory of excellence LABEX GRex Créteil France
- Sickle cell referral center, UMGGR Plateforme d'expertise Maladies Rares Grand Paris Est, UPEC Hôpitaux Universitaires Henri Mondor, APHP Créteil France
| | - Nadia Oubaya
- Hôpital Henri Mondor Assistance Publique‐Hôpitaux De Paris (APHP), Université Paris‐Est Créteil Créteil France
| | - Sadaf Pakdaman
- Institut Mondor de Recherche Biomédicale, Unité 955, team Pirenne, INSERM, EFS, UPEC, Laboratory of excellence LABEX GRex Créteil France
- Etablissement Français du Sang, Île‐de‐France, Hôpital Henri Mondor Créteil France
| | - Mehdi Sakka
- Hôpital Henri Mondor Assistance Publique‐Hôpitaux De Paris (APHP), Université Paris‐Est Créteil Créteil France
| | - Gaetana Di Liberto
- Institut Mondor de Recherche Biomédicale, Unité 955, team Pirenne, INSERM, EFS, UPEC, Laboratory of excellence LABEX GRex Créteil France
- Etablissement Français du Sang, Île‐de‐France, Hôpital Henri Mondor Créteil France
| | - Philippe Chadebech
- Institut Mondor de Recherche Biomédicale, Unité 955, team Pirenne, INSERM, EFS, UPEC, Laboratory of excellence LABEX GRex Créteil France
- Etablissement Français du Sang, Île‐de‐France, Hôpital Henri Mondor Créteil France
| | - Benoit Vingert
- Institut Mondor de Recherche Biomédicale, Unité 955, team Pirenne, INSERM, EFS, UPEC, Laboratory of excellence LABEX GRex Créteil France
- Etablissement Français du Sang, Île‐de‐France, Hôpital Henri Mondor Créteil France
| | - France Pirenne
- Institut Mondor de Recherche Biomédicale, Unité 955, team Pirenne, INSERM, EFS, UPEC, Laboratory of excellence LABEX GRex Créteil France
- Etablissement Français du Sang, Île‐de‐France, Hôpital Henri Mondor Créteil France
| | - Frédéric Galactéros
- Institut Mondor de Recherche Biomédicale, Unité 955, team Pirenne, INSERM, EFS, UPEC, Laboratory of excellence LABEX GRex Créteil France
- Sickle cell referral center, UMGGR Plateforme d'expertise Maladies Rares Grand Paris Est, UPEC Hôpitaux Universitaires Henri Mondor, APHP Créteil France
| | - Marie Cambot
- UMR_S1134, Université Sorbonne Paris Cité, Université Paris Diderot, Inserm, INTS, Unité Biologie Intégrée du Globule Rouge, Laboratory of excellence LABEX GRex Paris France
| | - Pablo Bartolucci
- Institut Mondor de Recherche Biomédicale, Unité 955, team Pirenne, INSERM, EFS, UPEC, Laboratory of excellence LABEX GRex Créteil France
- Sickle cell referral center, UMGGR Plateforme d'expertise Maladies Rares Grand Paris Est, UPEC Hôpitaux Universitaires Henri Mondor, APHP Créteil France
| |
Collapse
|
9
|
Bencheikh L, Imanci A, Plocque A, Solary É, Droin N. [Dynamic role of nuclear CSF1R in the monocytic lineage]. Med Sci (Paris) 2020; 35:1225-1227. [PMID: 31903947 DOI: 10.1051/medsci/2019236] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Affiliation(s)
- Laura Bencheikh
- Inserm U1170, Gustave Roussy, 94805 Villejuif, France - Université Paris-Sud, faculté de médecine, 94270 Le Kremlin-Bicêtre, France
| | - Aygun Imanci
- Inserm U1170, Gustave Roussy, 94805 Villejuif, France - Université Paris-Sud, faculté de médecine, 94270 Le Kremlin-Bicêtre, France
| | - Alexia Plocque
- Inserm U1170, Gustave Roussy, 94805 Villejuif, France - Université Paris-Sud, faculté de médecine, 94270 Le Kremlin-Bicêtre, France
| | - Éric Solary
- Inserm U1170, Gustave Roussy, 94805 Villejuif, France - Département d'hématologie, Gustave Roussy, 94805 Villejuif, France
| | - Nathalie Droin
- Inserm U1170, Gustave Roussy, 94805 Villejuif, France - Université Paris-Sud, faculté de médecine, 94270 Le Kremlin-Bicêtre, France - Inserm US23, CNRS UMS 3655, AMMICa, plateforme génomique, Gustave Roussy, 94805 Villejuif, France
| |
Collapse
|
10
|
Bencheikh L, Nguyen KA, Chadebech P, Kiger L, Bodivit G, Jouard A, Pakdaman S, Adypagavane S, Audureau E, Tebbakha K, Hebert N, Pirenne F, Sowemimo-Coker S, Dunham A, Bartolucci P. S906 PRECLINICAL EVALUATION OF THE PRESERVATION OF RED BLOOD CELL CONCENTRATES IN HYPOXIA BY HYPOXIC STORAGE TECHNOLOGY FOR TRANSFUSION IN SICKLE CELL DISEASE. Hemasphere 2019. [DOI: 10.1097/01.hs9.0000561904.90219.03] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022] Open
|
11
|
Bencheikh L, Diop MK, Rivière J, Imanci A, Pierron G, Souquere S, Naimo A, Morabito M, Dussiot M, De Leeuw F, Lobry C, Solary E, Droin N. Dynamic gene regulation by nuclear colony-stimulating factor 1 receptor in human monocytes and macrophages. Nat Commun 2019; 10:1935. [PMID: 31028249 PMCID: PMC6486619 DOI: 10.1038/s41467-019-09970-9] [Citation(s) in RCA: 22] [Impact Index Per Article: 4.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/23/2017] [Accepted: 04/10/2019] [Indexed: 02/06/2023] Open
Abstract
Despite their location at the cell surface, several receptor tyrosine kinases (RTK) are also found in the nucleus, as either intracellular domains or full length proteins. However, their potential nuclear functions remain poorly understood. Here we find that a fraction of full length Colony Stimulating Factor-1 Receptor (CSF-1R), an RTK involved in monocyte/macrophage generation, migrates to the nucleus upon CSF-1 stimulation in human primary monocytes. Chromatin-immunoprecipitation identifies the preferential recruitment of CSF-1R to intergenic regions, where it co-localizes with H3K4me1 and interacts with the transcription factor EGR1. When monocytes are differentiated into macrophages with CSF-1, CSF-1R is redirected to transcription starting sites, colocalizes with H3K4me3, and interacts with ELK and YY1 transcription factors. CSF-1R expression and chromatin recruitment is modulated by small molecule CSF-1R inhibitors and altered in monocytes from chronic myelomonocytic leukemia patients. Unraveling this dynamic non-canonical CSF-1R function suggests new avenues to explore the poorly understood functions of this receptor and its ligands. Receptor tyrosine kinases localize to the cell surface and have been suggested to also have nuclear function. Here the authors provide evidence that Colony Stimulating Factor-1 Receptor (CSF-1R) migrates to the nucleus upon CSF-1 stimulation in monocytes and that upon differentiation into macrophages, CSF-1R localizes to TSS, co-localizes with H3K4me3, and interacts with ELK and YY1.
Collapse
Affiliation(s)
- Laura Bencheikh
- INSERM U1170, Gustave Roussy Cancer Center, 94805, Villejuif, France.,Faculté de Médecine, Université Paris-Sud, 94270, Le Kremlin-Bicêtre, France
| | | | - Julie Rivière
- INSERM U1170, Gustave Roussy Cancer Center, 94805, Villejuif, France
| | - Aygun Imanci
- INSERM U1170, Gustave Roussy Cancer Center, 94805, Villejuif, France.,Faculté de Médecine, Université Paris-Sud, 94270, Le Kremlin-Bicêtre, France
| | - Gerard Pierron
- CNRS UMR9196, Gustave Roussy Cancer Center, 94805, Villejuif, France
| | - Sylvie Souquere
- CNRS UMR9196, Gustave Roussy Cancer Center, 94805, Villejuif, France
| | - Audrey Naimo
- INSERM US23, CNRS UMS 3655, AMMICa, Genomic platform, Gustave Roussy Cancer Center, 94805, Villejuif, France
| | - Margot Morabito
- INSERM U1170, Gustave Roussy Cancer Center, 94805, Villejuif, France
| | - Michaël Dussiot
- INSERM U1163, CNRS UMR8254, Institut Imagine, Hôpital Necker Enfants Malades, 75015, Paris, France.,Institut Imagine, Hôpital Necker Enfants Malades, Université Sorbonne-Paris-Cité, 75015, Paris, France.,Laboratoire d'excellence GR-Ex, Institut Imagine, Hôpital Necker Enfants Malades, 75015, Paris, France
| | - Frédéric De Leeuw
- INSERM US23, CNRS UMS 3655, AMMICa, Imaging and Cytometry Platform, Gustave Roussy Cancer Center, 94805, Villejuif, France
| | - Camille Lobry
- INSERM U1170, Gustave Roussy Cancer Center, 94805, Villejuif, France.,Faculté de Médecine, Université Paris-Sud, 94270, Le Kremlin-Bicêtre, France
| | - Eric Solary
- INSERM U1170, Gustave Roussy Cancer Center, 94805, Villejuif, France. .,Faculté de Médecine, Université Paris-Sud, 94270, Le Kremlin-Bicêtre, France. .,Department of Hematology, Gustave Roussy Cancer Center, 94805, Villejuif, France.
| | - Nathalie Droin
- INSERM U1170, Gustave Roussy Cancer Center, 94805, Villejuif, France. .,Faculté de Médecine, Université Paris-Sud, 94270, Le Kremlin-Bicêtre, France. .,INSERM US23, CNRS UMS 3655, AMMICa, Genomic platform, Gustave Roussy Cancer Center, 94805, Villejuif, France.
| |
Collapse
|
12
|
Boukezoula TF, Bencheikh L. Theoretical investigation of non-uniform bifunctional catalyst for the aromatization of methyl cyclopentane. Reac Kinet Mech Cat 2018. [DOI: 10.1007/s11144-017-1308-6] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
|